AlphAIalphai — Financial news for AI agents
investing.comAUG 72 min read$OKLO

Oklo reports wider Q2 loss despite revenue beat

Oklo Inc. (NYSE:OKLO) reported Q2 EPS loss of $0.28, worse than the $0.16 estimate, despite revenue of $1.2 million beating the $83.8k consensus. Net loss widened to $48.5 million from $24.7 million. R&D operating expenses rose to $39.5 million. Cash ended at $1.66 billion. Shares rose 4%.

Original reporting
investing.com
Published Aug 7, 2026, 11:38 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 11:57 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$OKLO
Bearish
medium confidence
Mentioned
$OKLO
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$OKLOBearishMed
01

Why it matters

For traders, the key decision inputs are the direction and magnitude of loss expansion (net loss and EPS) versus the cash runway improvement, plus whether R&D intensity signals progress or escalating burn.

02

Market read

A mixed earnings-style print can drive volatility: revenue beat may not offset the market’s focus on accelerating R&D and widening losses.

03

What to watch

Revenue beat is small in absolute terms ($1.2M) relative to the loss and R&D run-rate, so traders may need to separate early commercialization signals from ongoing burn.

Relevance 7/10Novelty 7/10Timing: reported Q2 results today, shares up ~4% on Friday

Background

The piece summarizes Oklo’s Q2 financial results, emphasizing EPS miss, revenue beat, net loss widening, and a major jump in R&D operating expenses.

Company-level read

Ticker impact

$OKLOBearishMedium confidence
Context

Oklo reported Q2 EPS of -$0.28, worse than the -$0.16 estimate, while revenue beat at $1.2M, and R&D surged to $39.5M.

Expected impact

Near-term volatility likely, with downside risk if investors focus on the loss expansion and R&D burn rather than the revenue beat.

Evidence & confidence

The article provides concrete P&L and cash figures (net loss widening, R&D up sharply, cash up materially) that directly inform burn-rate and runway expectations.

Market effects

Sector

Highlights cost-burn risk for nuclear/advanced energy developers, where revenue timing may lag heavy R&D spending.

Regional

No specific regional spillover beyond US small-cap risk appetite.

Global

Limited, as the disclosure is company-specific with no stated policy or regulatory catalyst.

Counterpoint

What could challenge this read

The large cash increase to $1.66B versus $226.8M prior-year could extend runway, making the R&D spike less immediately threatening than the headline loss widening suggests.

Key entities

  • company
    Oklo Inc.

    Reported Q2 EPS -$0.28 (miss), revenue $1.2M (beat), net loss $48.5M (widened), R&D operating expenses $39.5M (up sharply), and cash $1.66B (up).

Read at source← All news

Related articles

AUG 7
$OKLOMed

Oklo Inc. Q2 2026 Earnings Call Summary

Oklo Inc. reported progress from its Q2 2026 earnings call, including first criticality at the Groves isotope facility and plans for Aurora deployments at INL and an Ohio clean energy campus. The company targeted 2028 commercial startup, expected first isotope revenue in early 2027, and raised 2026 operating cash use guidance to $120M-$150M and PP&E spend to $400M-$500M.

yahoo.com10 min
AUG 7
$OKLOMed

Oklo Stock Attempts a Turnaround, but Technical Barriers Remain as It Releases Q2 2026 Financial Results

Oklo reported Q2 2026 revenue of $1.2 million, above analysts’ ~$83,800 estimate, but posted a $0.28 per-share loss versus a ~$0.16 consensus. Net loss widened to $48.5 million from $24.7 million a year earlier. The company ended the quarter with about $3 billion in cash and marketable securities and said its Groves Isotope Test Reactor achieved first criticality.

fxleaders.com6 min
AUG 7
$OKLOMedAI 8/10

Oklo reports $1.21M Q2 revenue, $1.6B cash as Aurora milestones advance

Oklo Inc. (NYSE: OKLO) reported Q2 2026 revenue of $1.21M versus a $126,250 analyst estimate and an EPS loss of $(0.28) versus an estimated $(0.16). The company said it ended the quarter with $1.6B cash and expects 2026 operating cash flow of $120M to $150M and capex of $400M to $500M. It also advanced Aurora regulatory steps and said its Groves reactor reached first criticality.

scanx.trade7 min
AUG 7
$OKLOMed

Oklo's Groves Reactor Just Achieved First Criticality. Here's What It Means for OKLO Stock.

Oklo said its Groves Isotope Test Reactor in Texas achieved first criticality on Aug. 5, marking the first self-sustaining fission chain reaction at the Groves site, according to the company. Oklo noted it was the first DOE Reactor Pilot Program project to reach criticality from a greenfield private-land site. The firm reiterated targets for Aurora-INL late 2027 to early 2028 and Aurora-Ohio startup in early 2030.

fool.com4 min
AUG 7
$OKLOMedAI 8/10

OKLO Q2 FY2026 earnings call — BigGo Finance

Oklo Inc. reported a first-half 2026 net loss of $81.6 million, with operating loss of $124.2 million offset by $44.5 million of net interest and dividend income, and no revenue recognized. Cash and marketable securities were $3.0 billion at June 30, 2026. Management raised FY2026 operating cash use to $120 million-$150 million and capex to $400 million-$500 million. Key updates include Groves first criticality and DOE progress for Aurora-INL.

finance.biggo.com7 min